RE: RE: News/FinancingYou are probably looking at 2012 for Phase 1. Right now we know the drug is non-toxic in rodents and we need to move from there and also the big question is what is the best way to administer the drug in humans. what the company is still working on is should this drug be administer via intravenus, pills or liquid or any other method of drug administration. Key will be the NR on the IND application.
Still a bag holder and always hoping for more info from the company when they can give it to us.